Dasatinib in Combination With Bevacizumab to Treat Advanced Solid Tumors
Clinical trial NCT01445509 · COMPLETED
Trial details
- NCT number
- NCT01445509
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-29
- Primary completion
- 2017-12-18
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.